Effects of Different Combinations of Phytochemical-Rich Fruits and Vegetables on Chronic Disease Risk Markers and Gene Expression Changes: Insights from the MiBLEND Study, a Randomized Trial.

Julia N DeBenedictis, Courtney Murrell, Duncan Hauser, Marcel van Herwijnen, Bart Elen, Theo M de Kok, Simone G van Breda
Author Information
  1. Julia N DeBenedictis: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands. ORCID
  2. Courtney Murrell: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
  3. Duncan Hauser: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
  4. Marcel van Herwijnen: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
  5. Bart Elen: Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium. ORCID
  6. Theo M de Kok: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
  7. Simone G van Breda: Toxicogenomics Department, GROW School of Oncology & Reproduction, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands. ORCID

Abstract

Adequate fruit and vegetable (F and V) intake, as recommended by the World Health Organization (over 400 g/day), is linked to reduced chronic disease risk. However, human intervention trials, especially with whole F and V and in complex combinations, are lacking. The MiBlend Study explored the effects of various phytochemical-rich F and V combinations on chronic disease risk markers, phytochemical absorption, and gene expression in blood. This randomized cross-over study involved participants consuming two of seven different F and V blends for 2 weeks (450 g/day), following a 2-week low F and V intake period (50 g/day). Each blend represented major phytochemical classes (flavonoids, anthocyanins, carotenoids, and glucosinolates) or combinations thereof. Markers of chronic disease risk, including DNA damage, oxidative stress, and retinal microvasculature, were measured. Increasing F and V intake significantly improved plasma antioxidant capacity, DNA damage protection, and retinal arteriolar dilation. Flavonoid-rich, carotenoid-rich, and complex blends notably reduced DNA damage susceptibility. Anthocyanin-rich and carotenoid-rich interventions were most effective in boosting antioxidant capacity, while blends high in flavonoids, especially combined with anthocyanins, significantly improved retinal microvasculature. Gene expression analysis revealed changes in DNA repair, signal transduction, and transcription processes, indicating mechanisms for these health benefits. The study suggests specific F and V blends can provide targeted health improvements, emphasizing the importance of both overall F and V intake and the specific phytochemical composition for personalized preventive strategies.

Keywords

References

  1. Br J Nutr. 2021 Mar 14;125(5):568-576 [PMID: 32513316]
  2. BMJ. 1999 Sep 11;319(7211):703-4 [PMID: 10480833]
  3. Eur J Nutr. 2020 Aug;59(5):2057-2063 [PMID: 31309281]
  4. Carcinogenesis. 2006 Apr;27(4):782-90 [PMID: 16364922]
  5. Antioxidants (Basel). 2019 Aug 02;8(8): [PMID: 31382522]
  6. Nutr Cancer. 2007;59(2):121-41 [PMID: 18001207]
  7. Curr Atheroscler Rep. 2014 Nov;16(11):452 [PMID: 25252787]
  8. J Nutr. 2003 Oct;133(10):3262S-3267S [PMID: 14519824]
  9. Food Sci Nutr. 2014 Nov;2(6):647-54 [PMID: 25493181]
  10. Am J Clin Nutr. 2007 Dec;86(6):1626-32 [PMID: 18065579]
  11. J Am Coll Cardiol. 2001 Dec;38(7):1788-94 [PMID: 11738275]
  12. Crit Rev Food Sci Nutr. 2014;54(9):1202-21 [PMID: 24499151]
  13. Br J Pharmacol. 2021 Apr;178(7):1605-1619 [PMID: 33486761]
  14. Front Oncol. 2021 Jun 21;11:705903 [PMID: 34235089]
  15. Antioxid Redox Signal. 2014 May 10;20(14):2107-13 [PMID: 24328558]
  16. Nutrients. 2018 Dec 29;11(1): [PMID: 30597948]
  17. Semin Cancer Biol. 2007 Oct;17(5):363-9 [PMID: 17555985]
  18. Curr Top Med Chem. 2011;11(14):1821-46 [PMID: 21506928]
  19. J Nutr. 2006 Aug;136(8):2207-12 [PMID: 16857842]
  20. Antioxid Redox Signal. 2001 Dec;3(6):1023-39 [PMID: 11813978]
  21. Nutr Cancer. 2010;62(3):329-35 [PMID: 20358470]
  22. J Agric Food Chem. 2011 May 11;59(9):4331-48 [PMID: 21438636]
  23. Am J Med. 2021 Jan;134(1):36-47.e7 [PMID: 32861624]
  24. Atherosclerosis. 2000 Nov;153(1):231-9 [PMID: 11058719]
  25. Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1171-7 [PMID: 9194770]
  26. Am J Clin Nutr. 2003 Jun;77(6):1466-73 [PMID: 12791625]
  27. Heart. 2010 Nov;96(21):1703-9 [PMID: 20736204]
  28. Nutrients. 2019 May 15;11(5): [PMID: 31096573]
  29. Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2677-81 [PMID: 11116071]
  30. Am J Clin Nutr. 2003 Sep;78(3 Suppl):559S-569S [PMID: 12936950]
  31. Dis Markers. 2018 May 2;2018:7916578 [PMID: 29854026]
  32. J Biomed Biotechnol. 2004;2004(5):321-325 [PMID: 15577196]
  33. BMC Bioinformatics. 2006 Feb 22;7:84 [PMID: 16504070]
  34. J Proteomics. 2017 Mar 6;156:94-103 [PMID: 28132875]
  35. Int J Vitam Nutr Res. 2021 Jan;91(1-2):77-86 [PMID: 31726948]
  36. Int J Epidemiol. 2017 Jun 1;46(3):1029-1056 [PMID: 28338764]
  37. Cancer Sci. 2009 Apr;100(4):715-21 [PMID: 19469016]
  38. Mol Nutr Food Res. 2018 Jan;62(1): [PMID: 29108107]
  39. Mutat Res. 1999 Jul 16;428(1-2):353-61 [PMID: 10518007]
  40. Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):491-7 [PMID: 19157815]
  41. Mutat Res Rev Mutat Res. 2023 Jan-Jun;791:108458 [PMID: 37031732]
  42. Molecules. 2020 May 16;25(10): [PMID: 32429384]
  43. Mutagenesis. 2015 Nov;30(6):723-31 [PMID: 25711498]
  44. Carcinogenesis. 2004 Nov;25(11):2207-16 [PMID: 15271855]
  45. Drug Metab Rev. 2015 May;47(2):175-90 [PMID: 25633078]
  46. Crit Rev Food Sci Nutr. 2013;53(7):706-21 [PMID: 23638931]
  47. Am J Clin Nutr. 2003 Jan;77(1):133-8 [PMID: 12499332]
  48. Mol Cell Biochem. 2004 Nov;266(1-2):109-15 [PMID: 15646031]
  49. Clin Epigenetics. 2015 Jul 10;7:64 [PMID: 26161152]
  50. J Nutr. 1999 Mar;129(3):768S-774S [PMID: 10082787]
  51. J Hypertens. 2003 Dec;21(12):2281-6 [PMID: 14654748]
  52. Circulation. 2009 Apr 28;119(16):2153-60 [PMID: 19364976]
  53. Mol Nutr Food Res. 2011 Jul;55(7):999-1009 [PMID: 21374800]
  54. Antioxidants (Basel). 2023 Jun 10;12(6): [PMID: 37371982]
  55. Genome Biol. 2010;11(3):R25 [PMID: 20196867]
  56. BMC Bioinformatics. 2017 Mar 2;18(1):142 [PMID: 28249561]
  57. J Nutr. 2003 Oct;133(10):3255S-3261S [PMID: 14519823]
  58. J Nutr. 2014 Jul;144(7):1067-74 [PMID: 24744306]
  59. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):313-9 [PMID: 14656738]
  60. Annu Rev Nutr. 2003;23:171-201 [PMID: 12626691]
  61. Food Chem Toxicol. 2012 Aug;50(8):2822-30 [PMID: 22664424]
  62. Carcinogenesis. 1996 Feb;17(2):277-82 [PMID: 8625450]
  63. Pharmacol Res. 2020 Jul;157:104830 [PMID: 32344050]
  64. J Nutr. 1999 Jan;129(1):5-8 [PMID: 9915867]
  65. Carcinogenesis. 1995 Apr;16(4):955-7 [PMID: 7728980]
  66. Small GTPases. 2016 Oct;7(4):207-221 [PMID: 27628050]
  67. Nutrients. 2017 Feb 26;9(3): [PMID: 28245627]
  68. Regul Toxicol Pharmacol. 2022 Jun;131:105143 [PMID: 35247516]
  69. Nutr Cancer. 2004;50(2):155-60 [PMID: 15623461]
  70. MMWR Morb Mortal Wkly Rep. 2022 Jan 07;71(1):1-9 [PMID: 34990439]
  71. Nutr Res. 2013 Mar;33(3):220-7 [PMID: 23507228]
  72. Mol Nutr Food Res. 2014 Jun;58(6):1379-83 [PMID: 24585444]
  73. Carcinogenesis. 2007 Aug;28(8):1800-6 [PMID: 17602170]
  74. Sci Data. 2022 Nov 14;9(1):699 [PMID: 36376331]
  75. Arch Biochem Biophys. 2013 Nov 15;539(2):171-80 [PMID: 23845854]
  76. Am J Clin Nutr. 2018 Nov 1;108(5):1069-1091 [PMID: 30475962]
  77. Br J Nutr. 2004 Jan;91(1):63-72 [PMID: 14748939]
  78. J Agric Food Chem. 2005 Oct 5;53(20):7749-59 [PMID: 16190627]
  79. Crit Rev Food Sci Nutr. 2020;60(13):2174-2211 [PMID: 31267783]
  80. Am J Clin Nutr. 2005 Jan;81(1 Suppl):215S-217S [PMID: 15640483]
  81. Cancer Res Treat. 2004 Oct;36(5):275-86 [PMID: 20368816]
  82. Mol Cancer Ther. 2007 Mar;6(3):1013-21 [PMID: 17339367]
  83. Am J Respir Crit Care Med. 2005 Apr 15;171(8):838-43 [PMID: 15579728]
  84. Epigenetics. 2013 Jun;8(6):612-23 [PMID: 23770684]
  85. Biosens Bioelectron. 2008 Dec 1;24(4):742-7 [PMID: 18718752]
  86. F1000Res. 2016 Jun 17;5:1408 [PMID: 27441086]
  87. Mol Cancer. 2011 May 30;10:68 [PMID: 21624135]
  88. Mol Cancer Ther. 2010 Jun;9(6):1596-608 [PMID: 20484017]
  89. Exp Biol Med (Maywood). 2007 Feb;232(2):227-34 [PMID: 17259330]
  90. Carcinogenesis. 1999 Dec;20(12):2261-6 [PMID: 10590217]
  91. Free Radic Biol Med. 2004 Apr 1;36(7):838-49 [PMID: 15019969]
  92. Oxid Med Cell Longev. 2012;2012:627843 [PMID: 22685620]
  93. J Pharmacol Pharmacother. 2011 Apr;2(2):107-11 [PMID: 21772771]
  94. Nutrients. 2016 Aug 29;8(9): [PMID: 27589790]
  95. Med Sci Monit. 2010 May;16(5):RA110-9 [PMID: 20424562]
  96. Mol Nutr Food Res. 2021 Oct;65(20):e2001214 [PMID: 34382747]
  97. Cardiovasc Drugs Ther. 2002 Jul;16(4):341-51 [PMID: 12652104]
  98. Eur J Clin Nutr. 2012 Mar;66(3):345-52 [PMID: 22127333]
  99. Crit Rev Food Sci Nutr. 2003;43(1):89-143 [PMID: 12587987]
  100. PLoS One. 2013 Aug 30;8(8):e73097 [PMID: 24023672]
  101. Drug Metab Rev. 2015 Aug;47(3):356-73 [PMID: 26119477]
  102. Molecules. 2014 Oct 24;19(11):17066-77 [PMID: 25347454]
  103. Small GTPases. 2018 May 4;9(3):203-215 [PMID: 27548350]
  104. Carcinogenesis. 1995 Sep;16(9):2125-8 [PMID: 7554064]
  105. Diabetes Care. 2003 May;26(5):1507-12 [PMID: 12716813]
  106. Oxid Med Cell Longev. 2012;2012:973927 [PMID: 22900129]
  107. Nutr Rev. 2013 Sep;71(9):585-99 [PMID: 24032363]

Grants

  1. N/A/Province of Limburg

Word Cloud

Created with Highcharts 10.0.0FVDNAintakediseaseriskblendsdamageg/daychroniccombinationsphytochemicalretinalantioxidantfruitreducedespeciallycomplexStudyexpressionstudyflavonoidsanthocyaninsMarkersmicrovasculaturesignificantlyimprovedcapacitycarotenoid-richGenehealthspecificAdequatevegetablerecommendedWorldHealthOrganization400linkedHoweverhumaninterventiontrialswholelackingMiBlendexploredeffectsvariousphytochemical-richmarkersabsorptiongenebloodrandomizedcross-overinvolvedparticipantsconsumingtwosevendifferent2weeks450following2-weeklowperiod50blendrepresentedmajorclassescarotenoidsglucosinolatesthereofincludingoxidativestressmeasuredIncreasingplasmaprotectionarteriolardilationFlavonoid-richnotablysusceptibilityAnthocyanin-richinterventionseffectiveboostinghighcombinedanalysisrevealedchangesrepairsignaltransductiontranscriptionprocessesindicatingmechanismsbenefitssuggestscanprovidetargetedimprovementsemphasizingimportanceoverallcompositionpersonalizedpreventivestrategiesEffectsDifferentCombinationsPhytochemical-RichFruitsVegetablesChronicDiseaseRiskExpressionChanges:InsightsMiBLENDRandomizedTrialnutrigenomicsphytochemicalspreventionsynergytranscriptomicsvegetables

Similar Articles

Cited By